Airway and alveolar nitric oxide measurements in obstructive sleep apnea syndrome

Respiratory Medicine

Volumn 105, Issue 4, 2011, Pages 630-636

  Fortuna, A M ^a,b   Miralda, R ^a,b   Calaf, N ^a,b   Gonzalez M ^a,b   Casan, P ^a,b   Mayos, M ^a,b  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Alveolar nitric oxide; Exhaled nitric oxide; Obstructive sleep apnea; Oxidative stress

Indexed keywords

NITRIC OXIDE;

ADULT; AIRWAY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EXPIRED AIR; FEMALE; HUMAN; HUMAN EXPERIMENT; LUNG ALVEOLUS; LUNG BLOOD VESSEL; MALE; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; SLEEP APNEA SYNDROME; VASODILATATION;

ANOXIA; CARDIOVASCULAR DISEASES; CONTINUOUS POSITIVE AIRWAY PRESSURE; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NITRIC OXIDE; PULMONARY ALVEOLI; SLEEP APNEA, OBSTRUCTIVE;

EID: 79952280469     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2010.12.004     Document Type: Article

References (37)

1. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population heath perspective. Am J Respir Crit Care Med 2002;165:1217-39. (Pubitemid 34461732)
2. Epstein LJ, Cristo D, Strollo PJ, et al. Adult obstructive sleep apnea task force of the American academy of sleep medicine. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med 2009;15(3):263-76.
3. Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study: sleep heart health study. JAMA 2000;283:1829-36. (Pubitemid 30207619)
4. McNicholas WT. Bonsignore MR and the management committee of EU COST ACTION B26. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 2007;29:156-78.
5. Marin JM, Carrizo SJ, Vicente E, et al. Long-term cardiovascular outcomes in men with obstructive sleep apnea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005;365:1046-53. (Pubitemid 40386782)
6. Ryan S, Taylor CT, McNicholas WT. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 2005;112:2660-7. (Pubitemid 41532603)
7. Barceló A, Barbé F, de la Peña M, et al. Antioxidant status in patients with sleep apnea and impact of continuous positive airway pressure treatment. Eur Respir J 2006;27:756-60. (Pubitemid 44914199)
8. Barceló A, Miralles C, Barbé F, et al. Abnormal lipid peroxidation in patients with sleep apnea. Eur Respir J 2000;16:644-7.
9. Gozal D, Kheirandish-Gozal L. Cardiovascular morbidity in obstructive sleep apnea: oxidative stress, inflammation, and much more. Am J Respir Crit Care Med 2008;177(4):369-75. (Pubitemid 351317579)
10. Lavie L. Obstructive sleep apnoea syndrome - an oxidative stress disorder. Sleep Med Rev 2003;7:35-51. (Pubitemid 36188305)
11. Phillips CL, Grunstein RR. Obstructive sleep apnoea: time for a radical change? Eur Respir J 2006;27:671-3.
12. Moilanen E, Whittle BRJ, Moncada S. Nitric oxide as a factor in inflammation. In: Gallin JI, Snyderman S, Fearon DT, et al., editors. Inflammation: basic Principles and clinical Correlates. Philadelphia: Williams & Wilkins; 1999. p. 787-801.
13. Ip MSM, Lam B, Chan L-Y, et al. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med 2000;162:2166-71. (Pubitemid 32051681)
14. Kharitonov SA, Barnes PJ. Clinical aspects of exhaled nitric oxide. Eur Respir J 2000;16:781-92.
15. Lavi S, Yang EH, Prasad A, et al. The interaction between coronary endothelial dysfunction, local oxidative stress, and endogenous nitric oxide in humans. Hypertension 2008;51:127-33. (Pubitemid 350307114)
16. Depalo A, Carpagnano GE, Spanvello A, et al. Exhaled NO and iNOS expression in sputum cells of healthy, obese and OSA subjects. J Intern Med 2008;263:70-8. (Pubitemid 350243547)
17. Petrosyan M, Perraki E, Simoes D, et al. Exhaled breath markers in patients with obstructive sleep apnoea. Sleep Breath 2008;12:207-15.
18. Foresi A, Leone C, Olivieri D, Cremona G. Alveolar-derived exhaled nitric oxide is reduced in obstructive sleep apnea syndrome. Chest 2007;132:860-7.
19. White J, Cates C, Wright J. Continuous positive airways pressure for obstructive sleep apnea. Cochrane Database Syst Rev 2002;2. CD001106.
20. Barbé F, Mayoralas LR, Duran J, et al. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. a randomized, controlled trial. Ann Intern Med 2001;134(11):1015-23. (Pubitemid 32488655)
21. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540-5.
22. Masa JF, Jimenez A, Duran J, et al. Grupo Español de Sueño. Alternative methods of titrating continuous positive airway pressure: a large multicenter study. Am J Respir Crit Care Med 2004;170(11):1218-24. (Pubitemid 39577381)
23. Rechtschaffen A, Kales A. A manual of standardized terminology techniques and scoring systems for sleep stages of human subjects. Washington: DC US-Government Printing Office; 1968.
24. EEG arousals: scoring rules and examples: a preliminary report from the sleep disorders atlas task force of the American sleep disorders association. Sleep 1992;15:173-84.
25. Collop NA, Anderson WM, Boehlecke B, et al. Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patients. Portable monitoring task force of the American Academy of sleep medicine. Clin Sleep Med 2007;3(7):737-47. (Pubitemid 351204505)
26. Standardization of spirometry. Statement of the American thoracic Society. Am Rev Respir Dis 1987;136:1285-98.
27. American Thoracic Society. Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children. Am J Respir Crit Care Med 2005;171:912-30.
28. Fortuna AM, Balleza M, Calaf N, González M, Feixas T, Casan P. Determinación de la concentración de óxido nítrico alveolar en aire espirado: procedimiento y valores de referencia en personas sanas. Arch Bronconeumol 2009;45:145-9.
29. George SC, Hogman M, Permutt S, Silkoff PE. Modeling pulmonary nitric oxide exchange. J Appl Physiol 2004;96:831-9. (Pubitemid 38248651)
30. Hatipoglu U, Rubinstein I. Inflammation and obstructive sleep apnea syndrome pathogenesis: a working hypothesis. Respiration 2003;70:665-71. (Pubitemid 38142324)
31. Salerno FG, Carpagnano E, Guido P, et al. Airway inflammation in patients affected by obstructive sleep apnea syndrome. Respir Med 2004;98:25-8. (Pubitemid 38100751)
32. Devouassoux G, Lévy P, Rossini E, et al. Sleep apnoea is associated with bronchial inflammation and continuous positive airway pressure-induced airway hyperresponsiveness. J Allergy Clin Immunol 2007;119:597-603.
33. Olopade CO, Christon JA, Zakkar M, et al. Exhaled pentane and nitric oxide levels in patients with obstructive sleep apnea. Chest 1997;111:1500-4. (Pubitemid 27260072)
34. Culla B, Guida G, Brussino L, et al. Increased oral nitric oxide in obstructive sleep apnea. Respir Med 2010;104(2):316-20.
35. Wever RM, Van Dam T, Van Rijn HJ, et al. Tetrahydrobiopterin regulates superoxide and nitric oxide generation by recombinant endothelial nitric oxide synthase. Biochem Biophys Res Commun 1997;237:340-4. (Pubitemid 27406031)
36. Salord N, Mayos M, Miralda R, et al. Respiratory sleep disturbances in patients undergoing gastric bypass surgery and their relation to metabolic syndrome. Obes Surg 2009;19(1):74-9.
37. Jelic S, Leaderer DJ, Adams T, et al. Vascular inflammation in obesity and sleep apnea. Circulation 2010;121(8):1014-21.